The Incidence of Pelvic Hematoma Following Hysterectomy
NCT ID: NCT01498315
Last Updated: 2014-05-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
39 participants
OBSERVATIONAL
2012-03-31
2014-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ultrasound for Assessment of Intra-Abdominal Blood Loss After Gynecological Surgery
NCT06953141
Long-term Outcomes After Laparoscopic Subtotal and Total Hysterectomy
NCT05421156
Lateral Occlusion of Uterine Artery in Total Laparoscopic Hysterectomy
NCT02709460
Major Pelvic Hemorrhage in Complex Surgery
NCT04264988
Vaginal Stump Infection After Laparoscopic Hysterectomy
NCT04725981
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Women following hysterecomy
Ultrasound examination
Ultrasound examination following hysterectomy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ultrasound examination
Ultrasound examination following hysterectomy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
18 Years
80 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Carmel Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ron Auslender
Head of Obstetric and Gynecology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ron Auslender, Dr
Role: PRINCIPAL_INVESTIGATOR
Carmel Medical Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CMC-11-0073-CTIL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.